| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | C04AX32 |
| UNII: | Q0CH43PGXS |
| InChI Key | NGOGFTYYXHNFQH-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C14H17N3O2S |
| Molecular Weight | 291.38 |
| AlogP | 1.22 |
| Hydrogen Bond Acceptor | 4.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 2.0 |
| Polar Surface Area | 62.3 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 20.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Rho-associated protein kinase inhibitor | PubMed |
| Primary Target | |
|---|---|
| Rho associated coiled-coil containing protein kinase 1 | |
| Rho associated coiled-coil containing protein kinase 2 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Amyotrophic Lateral Sclerosis | 2 | D000690 | ClinicalTrials |
| Retinal Vein Occlusion | 2 | D012170 | ClinicalTrials |
| Retinopathy of Prematurity | 2 | D012178 | ClinicalTrials |
| Dementia | 2 | D003704 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 103745-39-7 |
| ChEMBL | CHEMBL38380 |
| DrugBank | DB08162 |
| DrugCentral | 1132 |
| EPA CompTox | DTXSID4048569 |
| FDA SRS | Q0CH43PGXS |
| Guide to Pharmacology | 5181 |
| PDB | M77 |
| PubChem | 3547 |
| SureChEMBL | SCHEMBL4674 |
| ZINC | ZINC000000006486 |